NASDAQ:AQST - Aquestive Therapeutics News Headlines

$4.13
-0.14 (-3.28 %)
(As of 07/17/2019 04:00 PM ET)
Today's Range
$4.00
Now: $4.13
$4.29
50-Day Range
$3.72
MA: $4.25
$4.93
52-Week Range
$3.65
Now: $4.13
$20.70
Volume63,135 shs
Average Volume150,348 shs
Market Capitalization$103.17 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Aquestive Therapeutics (NASDAQ AQST) News Headlines

Source:
DateHeadline
What Percentage Of Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares Do Insiders Own?What Percentage Of Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares Do Insiders Own?
finance.yahoo.com - July 17 at 3:43 PM
Aquestive Therapeutics Completes $70 Million Debt RefinancingAquestive Therapeutics Completes $70 Million Debt Refinancing
finance.yahoo.com - July 16 at 11:33 AM
Aquestive Therapeutics Inc (NASDAQ:AQST) Short Interest UpdateAquestive Therapeutics Inc (NASDAQ:AQST) Short Interest Update
www.americanbankingnews.com - July 11 at 6:33 PM
Wedbush Analysts Give Aquestive Therapeutics (NASDAQ:AQST) a $31.00 Price TargetWedbush Analysts Give Aquestive Therapeutics (NASDAQ:AQST) a $31.00 Price Target
www.americanbankingnews.com - July 8 at 4:00 PM
Aquestive Therapeutics Inc (NASDAQ:AQST) Expected to Announce Quarterly Sales of $10.45 MillionAquestive Therapeutics Inc (NASDAQ:AQST) Expected to Announce Quarterly Sales of $10.45 Million
www.americanbankingnews.com - June 30 at 3:26 AM
-$0.67 Earnings Per Share Expected for Aquestive Therapeutics Inc (NASDAQ:AQST) This Quarter-$0.67 Earnings Per Share Expected for Aquestive Therapeutics Inc (NASDAQ:AQST) This Quarter
www.americanbankingnews.com - June 28 at 10:12 AM
Aquestive Therapeutics Inc (NASDAQ:AQST) Receives Average Recommendation of "Buy" from BrokeragesAquestive Therapeutics Inc (NASDAQ:AQST) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - June 27 at 4:29 AM
Heron Could Be The Next Home Run In Combating The OpiodemicHeron Could Be The Next Home Run In Combating The Opiodemic
seekingalpha.com - June 18 at 2:20 PM
Aquestive Therapeutics Completes Enrollment in Libervant™ (diazepam buccal film) Crossover StudyAquestive Therapeutics Completes Enrollment in Libervant™ (diazepam buccal film) Crossover Study
finance.yahoo.com - June 4 at 12:02 PM
Aquestive Therapeutics to Present at Two Upcoming Investor ConferencesAquestive Therapeutics to Present at Two Upcoming Investor Conferences
finance.yahoo.com - May 13 at 12:02 PM
New operating chief at AquestiveNew operating chief at Aquestive
seekingalpha.com - May 8 at 12:09 PM
Aquestive Therapeutics: 1Q Earnings SnapshotAquestive Therapeutics: 1Q Earnings Snapshot
finance.yahoo.com - May 8 at 12:08 PM
Need To Know: Aquestive Therapeutics, Inc. (NASDAQ:AQST) Insiders Have Been Buying SharesNeed To Know: Aquestive Therapeutics, Inc. (NASDAQ:AQST) Insiders Have Been Buying Shares
finance.yahoo.com - April 27 at 11:36 AM
Aquestive Therapeutics to Announce First Quarter 2019 Financial Results and Recent Business Highlights on May 8, 2019Aquestive Therapeutics to Announce First Quarter 2019 Financial Results and Recent Business Highlights on May 8, 2019
finance.yahoo.com - April 18 at 12:34 PM
FDA accepts Aquestives application for riluzole oral film for ALSFDA accepts Aquestive's application for riluzole oral film for ALS
seekingalpha.com - April 16 at 1:38 PM
Aquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Acceptance of New Drug Application for Riluzole Oral Film for Treatment of ALSAquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Acceptance of New Drug Application for Riluzole Oral Film for Treatment of ALS
finance.yahoo.com - April 16 at 1:38 PM
Aquestive Therapeutics to Present at H.C. Wainwright Global Life Sciences ConferenceAquestive Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 26 at 12:28 PM
Aquestive Therapeutics (AQST) Upgraded to Buy: Heres WhyAquestive Therapeutics (AQST) Upgraded to Buy: Here's Why
finance.yahoo.com - March 21 at 11:10 AM
Aquestive Therapeutics (AQST) Upgraded to Buy: Here's WhyAquestive Therapeutics (AQST) Upgraded to Buy: Here's Why
finance.yahoo.com - March 21 at 11:10 AM
Aquestive Therapeutics, Inc. Estimate MomentumAquestive Therapeutics, Inc. Estimate Momentum
www.nasdaq.com - March 18 at 3:57 PM
Aquestive Therapeutics, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Business HighlightsAquestive Therapeutics, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Business Highlights
finance.yahoo.com - March 14 at 12:31 PM
Aquestive Therapeutics: 4Q Earnings SnapshotAquestive Therapeutics: 4Q Earnings Snapshot
finance.yahoo.com - March 14 at 12:31 PM
Aquestive Therapeutics to Present at Oppenheimers 29th Annual Healthcare ConferenceAquestive Therapeutics to Present at Oppenheimer's 29th Annual Healthcare Conference
finance.yahoo.com - March 7 at 3:48 PM
Aquestive Therapeutics: Specialty Pharma Company With Multiple Value DriversAquestive Therapeutics: Specialty Pharma Company With Multiple Value Drivers
seekingalpha.com - March 1 at 12:26 PM
Aquestive Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results and Recent Business Highlights on March 14, 2019Aquestive Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results and Recent Business Highlights on March 14, 2019
finance.yahoo.com - February 19 at 11:43 AM
Aquestive Therapeutics to Present at 2019 BIO CEO & Investor ConferenceAquestive Therapeutics to Present at 2019 BIO CEO & Investor Conference
finance.yahoo.com - February 8 at 11:39 AM
Aquestive Therapeutics Provides Update Regarding Suboxone® Sublingual Film LitigationAquestive Therapeutics Provides Update Regarding Suboxone® Sublingual Film Litigation
finance.yahoo.com - February 5 at 10:38 AM
Aquestive down 29% premarket on Sunovion CRL for Parkinsons candidateAquestive down 29% premarket on Sunovion CRL for Parkinson's candidate
seekingalpha.com - January 31 at 11:27 AM
Aquestive Therapeutics Provides Update on Licensee, Sunovion Pharmaceuticals Inc.s Apomorphine Sublingual Film (APL-130277) New Drug ApplicationAquestive Therapeutics Provides Update on Licensee, Sunovion Pharmaceuticals Inc.'s Apomorphine Sublingual Film (APL-130277) New Drug Application
finance.yahoo.com - January 31 at 11:27 AM
Aquestive Therapeutics Granted Temporary Restraining Order (TRO) Against AlvogenAquestive Therapeutics Granted Temporary Restraining Order (TRO) Against Alvogen
finance.yahoo.com - January 25 at 3:37 PM
Aquestive Therapeutics Inc.Aquestive Therapeutics Inc.
www.barrons.com - January 4 at 3:29 PM
Aquestive Therapeutics Appoints Gary H. Slatko, M.D. as Chief Medical OfficerAquestive Therapeutics Appoints Gary H. Slatko, M.D. as Chief Medical Officer
finance.yahoo.com - January 4 at 9:34 AM
Needham sees 27% upside in Thermo Fisher in todays analyst actionNeedham sees 27% upside in Thermo Fisher in today's analyst action
seekingalpha.com - January 3 at 3:31 PM
Aquestive Therapeutics, Inc.’s (NASDAQ:AQST) Shift From Loss To ProfitAquestive Therapeutics, Inc.’s (NASDAQ:AQST) Shift From Loss To Profit
finance.yahoo.com - December 21 at 3:27 PM
Aquestive Therapeutics provides year end business updateAquestive Therapeutics provides year end business update
seekingalpha.com - December 20 at 9:45 AM
Aquestive Therapeutics Schedules Business Update...Aquestive Therapeutics Schedules Business Update...
www.benzinga.com - December 19 at 9:39 AM
Aquestive Therapeutics schedules business update conference call on December 20Aquestive Therapeutics schedules business update conference call on December 20
seekingalpha.com - December 19 at 9:39 AM
Aquestive Therapeutics Schedules Business Update Conference Call on December 20, 2018Aquestive Therapeutics Schedules Business Update Conference Call on December 20, 2018
finance.yahoo.com - December 19 at 9:39 AM
Aquestive Therapeutics to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare ConferenceAquestive Therapeutics to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference
finance.yahoo.com - December 7 at 8:43 AM
Aquestive Therapeutics (AQST) nnounces Late-Breaking Findings of its Investigational DBF Formulation in Adults with EpilepsyAquestive Therapeutics (AQST) nnounces Late-Breaking Findings of its Investigational DBF Formulation in Adults with Epilepsy
www.streetinsider.com - December 3 at 3:22 PM
Aquestive Therapeutics Announces Late-Breaking Findings of its Investigational Diazepam Buccal Film (DBF) Formulation in Adults with EpilepsyAquestive Therapeutics Announces Late-Breaking Findings of its Investigational Diazepam Buccal Film (DBF) Formulation in Adults with Epilepsy
finance.yahoo.com - December 3 at 3:22 PM
Aquestive continues post-CRL selloff, shares down 6%Aquestive continues post-CRL selloff, shares down 6%
seekingalpha.com - November 30 at 3:23 PM
Aquestive launches Sympazan in U.S.Aquestive launches Sympazan in U.S.
seekingalpha.com - November 29 at 3:23 PM
Aquestive Therapeutics (AQST) Launches SYMPAZAN Oral FilmAquestive Therapeutics (AQST) Launches SYMPAZAN Oral Film
www.streetinsider.com - November 29 at 3:23 PM
Aquestive Therapeutics Launches SYMPAZAN™ (clobazam) Oral Film with Widespread U.S. AvailabilityAquestive Therapeutics Launches SYMPAZAN™ (clobazam) Oral Film with Widespread U.S. Availability
finance.yahoo.com - November 29 at 3:23 PM
The Week Ahead In Biotech: Earnings, Conferences, PDUFA DatesThe Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates
finance.yahoo.com - November 19 at 8:02 AM
Aquestive Therapeutics Receives Complete Response Letter from U.S. Food and Drug Administration (FDA) for Tadalafil Oral FilmAquestive Therapeutics Receives Complete Response Letter from U.S. Food and Drug Administration (FDA) for Tadalafil Oral Film
finance.yahoo.com - November 17 at 8:12 AM
Aquestive Therapeutics (AQST) CEO Keith Kendall on Q3 2018 Results - Earnings Call TranscriptAquestive Therapeutics (AQST) CEO Keith Kendall on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 11 at 3:24 PM
New Erectile Dysfunction Treatment Likely to Face Stiff Competition If ApprovedNew Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved
247wallst.com - November 8 at 3:24 PM
Aquestive Therapeutics Reports Third Quarter 2018 Financial Results and Recent Business HighlightsAquestive Therapeutics Reports Third Quarter 2018 Financial Results and Recent Business Highlights
finance.yahoo.com - November 7 at 7:49 AM
This page was last updated on 7/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel